New research suggests your vaccine-induced antibodies will protect you from COVID-19 for at least six months.
Antibody presence is particularly important when looking at vaccine efficacy, Suthar says.
The antibodies bind to the appropriate regions in the virus to prevent it from actually infecting a cell.
Jasmin Merdan / Getty Images
They dont stay at a constant level, Doria-Rose says.
Six months after their second dose, antibodies remained high in all age groups.
You may need to receive a booster shot in the future, but that remains to be determined.
Researchers examined three different age groups:
They discovered that the prevalence of antibodies did decrease in older participants.
“Older people have immune systems that arent as strong as younger peoples immune systems, Doria-Rose says.
Research shows that older people have reduced vaccination longevity and levels of antibodies post-vaccination.
Initially, the vaccines were designed to protect people against the first COVID-19 strain.
Now, new mutations pose a challenge to vaccine development.
When new variants are discovered, this poses a challenge to researchers like Suthar and Doria-Rose.
One of the byproducts is it can now develop ways to be able to evade antibody response.
We just hope that the vaccines that have been designed still maintain that level of protection against these variants.
Were going to be doing the one-year samples soon,” Doria-Rose says.
For the most recent updates on COVID-19, visit ourcoronavirus news page.
doi:10.1056/NEJMc2103916
Lord JM.The effect of aging of the immune system on vaccination responses.Hum Vaccin Immunother.
2013;9(6):1364-1367. doi:10.4161/hv.24696
